Recent Trials

Brazil

Alecardio
Spire I & II

Alecardio

Effect Of Aleglitazar On Cardiovascular Outcomes After Acute Coronary Syndrome With Type 2 Diabetes Mellitus.

Study Metrics

Sites Initiated

40

Sites Randomized

37

Patients Screened

622

Patients Randomized

533

Previous Experience in Brazil

Other Trials

Cardiology

Trials
0
Sites Enrolled
0
Patients Enrolled
0

Oncology

Trials
0
Sites Enrolled
0
Patients Enrolled
0

Infectious Disease

Trials
0
Sites Enrolled
0
Patients Enrolled
0

CNS

Trials
0
Sites Enrolled
0
Patients Enrolled
0

Trials in Other Countries

Argentina - Colombia - Mexico

Colombia

Trials

Mexico

Trials

Argentina

Trials

Interested in Latin America?

Request a free consultation with our regional experts